Chemours Q2 net loss $381M; adjusted EBITDA up 22% to $253M; NJ PFAS settlement reached

Chemours Co

2025-Q2 EPS reported -$2.56 revenue$2,983,000,000

Net loss of $381M ($2.54 diluted EPS) vs net income $60M ($0.39) in Q2 2024; adjusted net income $87M ($0.58).
Net sales $1.615B, up 4% YoY; TSS Opteon Refrigerants grew 65% year-over-year.
Adjusted EBITDA $253M, up 22% from $207M in prior-year quarter.
Reached comprehensive settlement with New Jersey resolving all statewide PFAS environmental claims.
Declared quarterly cash dividend of $0.0875 per share for Q3 2025.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.